This is a randomized, parallel two-arm clinical trial design to study the efficacy of time-restricted feeding on metabolic risk in postmenopausal women, who may be particularly vulnerable to disruption of circadian eating rhythms and the associated metabolic dysfunction. It is hypothesized that time-restricted feeding will improve insulin sensitivity, glucose tolerance, body weight, and other metabolic parameters in metabolically-unhealthy postmenopausal women.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Change in Insulin Sensitivity
Timeframe: 18 weeks (baseline and post-intervention)
Change in Body Mass Index
Timeframe: 18 weeks (baseline and post-intervention)
Change in Triglycerides
Timeframe: 18 weeks (baseline and post-intervention)